A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

PURPOSE: This study investigated the effect of dual bronchodilation with the long-acting β-receptor agonist/long-acting muscarinic antagonist combination, indacaterol/glycopyrronium (IND/GLY), on nighttime oxygenation, lung function, sleep quality, and symptoms in patients with moderate-to-severe CO...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Chron Obstruct Pulmon Dis
Prif Awduron: Lehmann, Sverre, Ringbæk, Thomas, Løkke, Anders, Grote, Ludger, Hedner, Jan, Lindberg, Eva
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2019
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6330967/
https://ncbi.nlm.nih.gov/pubmed/30666100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S184127
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg